CLASS II ONGOING Device recall · Reported 14 Jul 2021 · FDA Enforcement Report

Verigene Gram Negative Blood Culture Nucleic Acid Test v2 (BC-GNv2) recalled

Luminex is recalling Verigene Gram Negative Blood Culture Nucleic Acid Test v2 (BC-GNv2), distributed nationwide in the US. The recall was initiated on 30 Oct 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes050620026A and 072120026B,
Quantity recalled165

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2011-2021
FDA event ID
88137
Recalling firm
Luminex, Northbrook, IL
Classification
Class II
Status
Ongoing
Recall initiated
30 Oct 2020
FDA classified
2 Jul 2021
Reported
14 Jul 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Oct 2020Recall initiated by company
2 Jul 2021Classified by FDA+245 days
14 Jul 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for a false-negative result.

Product as listed by the FDA

Verigene Gram Negative Blood Culture Nucleic Acid Test v2 (BC-GNv2) Model Number: 20-006-026

Where it was distributed

Worldwide distribution - US Nationwide including in the states of AL, AZ, CA, CO, CT, DE, DC, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, NE, NV, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA and VT. The countries of Austria, Chile, France, Germany, Greece, Italy, Japan, Kuwait, Netherlands, Spain, Thailand, Turkey, and United Kingdom.

Nationwide AlabamaArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaineMichigan

Questions about this recall

Why was it recalled?

Potential for a false-negative result.

Which lots are affected?

050620026A and 072120026B,

Where was it sold?

Worldwide distribution - US Nationwide including in the states of AL, AZ, CA, CO, CT, DE, DC, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, NE, NV, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA and VT. The countries of Austria, Chile, France, Germany, Greece, Italy, Japan, Kuwait, Netherlands, Spain, Thailand, Turkey, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 88137

This product is part of a recall event; the main page for the event is Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) recalled.

More recalls from Luminex

All 39

Other Other Medical Devices recalls

All 13,778